Recurrent IDH1/2 mutations were found in 20% of AML patients, and these mutations transformed isocitrate into 2-HG instead of the original a-KG in the tricarboxylic acid cycle, leading to the accumulation of 2-HG and a decrease in a-KG. The gene discussed is IDH1; the disease is acute myeloid leukemia.